Dengue vaccines: closer but not there yet [PDF]
Galler, Ricardo +2 more
openaire +4 more sources
The Tolerability of the Dengue Vaccine TAK-003 (Qdenga<sup>®</sup>) in German Travelers: The Results of a Prospective Survey. [PDF]
Jelinek T, Kramm J, Wagner M, Jelinek C.
europepmc +1 more source
Defining a Simplified Process in Yeast for Production of Enveloped VLP Dengue Vaccine. [PDF]
de Sá Magalhães S +5 more
europepmc +1 more source
Dengue Vaccine Development and Deployment into Routine Immunization. [PDF]
Wilder-Smith A, Cherian T, Hombach J.
europepmc +1 more source
Acceptance of a dengue vaccine and potential change in vector control behavior. [PDF]
Ponmattam J +4 more
europepmc +1 more source
Acceptability of a chikungunya vaccine and dengue vaccine among travelers in Martinique (French West Indies), for the travel and for their home territory. [PDF]
Quenard F +6 more
europepmc +1 more source
Recommendations for dengue vaccine implementation in the elderly population. [PDF]
Giang NNT, Taylor-Robinson AW.
europepmc +1 more source
Cross-genotype immunogenicity and antibody-dependent enhancement of KD-382 dengue vaccine in flavivirus-naïve adults. [PDF]
Balingit JC +7 more
europepmc +1 more source
Correction: Vaccination strategies, public health impact and cost-effectiveness of dengue vaccine TAK-003: A modeling case study in Thailand. [PDF]
Shen J +10 more
europepmc +1 more source
Overcoming dengue vaccine challenges through next-generation virus-like particle immunization strategies. [PDF]
Parra-González M +5 more
europepmc +1 more source

